Find Zavegepant HCl manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

KDMF

KDMF

0

VMF

NDC API

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

Health Canada Patents

API REF. PRICE (USD/KG)

GLOBAL SALES INFORMATION

Annual Reports

NA

Regulatory FDF Prices

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

FDF

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Vazegepant, Bms-742413, Bhv-3500, Zavegepant [usan], Odu3zaz94j, Bms-742413-01
Molecular Formula
C36H46N8O3
Molecular Weight
638.8  g/mol
InChI Key
JJVAPHYEOZSKJZ-JGCGQSQUSA-N
FDA UNII
ODU3ZAZ94J

Zavegepant HCl
Zavegepant is a highly soluble small molecule calcitonin gene related peptide (CGRP) receptor antagonist, with potential analgesic and immunomodulating activities. Upon administration, zavegepant targets, binds to and inhibits the activity of CGRP receptors located on mast cells in the brain. This may inhibit neurogenic inflammation caused by trigeminal nerve release of CGRP. In addition, by blocking the CGRP receptors located in smooth muscle cells within vessel walls, zavegepant inhibits the pathologic dilation of intracranial arteries. Zavegepant, by blocking the CGRP receptors, also suppresses the transmission of pain by inhibiting the central relay of pain signals from the trigeminal nerve to the caudal trigeminal nucleus. Altogether, this may relieve migraine. As CGRP receptors induce the release of pro-inflammatory mediators, such as interleukin-6 (IL-6), from inflammatory cells, zavegepant may prevent an IL-6-mediated inflammatory response. Zavegepant may also inhibit the CGRP-mediated induction of eosinophil migration and the stimulation of beta-integrin-mediated T cell adhesion to fibronectin at the site of inflammation, and may abrogate the CGRP-mediated polarization of the T cell response towards the pro-inflammatory state characterized by Th17 and IL-17. This may improve lung inflammation and oxygenation, prevent edema, and further lung injury. CGRP, a 37 amino-acid peptide expressed in and released from a subset of polymodal primary sensory neurons of the trigeminal ganglion and nerve fibers projecting to the airways and by pulmonary neuroendocrine cells, plays an important role in pain transmission, inflammation, and neurogenic vasodilatation. It is released upon acute lung injury and upregulation of transient receptor potential (TRP) channels.
1 2D Structure

Zavegepant HCl

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
N-[(2R)-3-(7-methyl-1H-indazol-5-yl)-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-1-oxopropan-2-yl]-4-(2-oxo-1H-quinolin-3-yl)piperidine-1-carboxamide
2.1.2 InChI
InChI=1S/C36H46N8O3/c1-24-19-25(20-28-23-37-40-33(24)28)21-32(35(46)43-17-15-42(16-18-43)29-9-11-41(2)12-10-29)39-36(47)44-13-7-26(8-14-44)30-22-27-5-3-4-6-31(27)38-34(30)45/h3-6,19-20,22-23,26,29,32H,7-18,21H2,1-2H3,(H,37,40)(H,38,45)(H,39,47)/t32-/m1/s1
2.1.3 InChI Key
JJVAPHYEOZSKJZ-JGCGQSQUSA-N
2.1.4 Canonical SMILES
CC1=CC(=CC2=C1NN=C2)CC(C(=O)N3CCN(CC3)C4CCN(CC4)C)NC(=O)N5CCC(CC5)C6=CC7=CC=CC=C7NC6=O
2.1.5 Isomeric SMILES
CC1=CC(=CC2=C1NN=C2)C[C@H](C(=O)N3CCN(CC3)C4CCN(CC4)C)NC(=O)N5CCC(CC5)C6=CC7=CC=CC=C7NC6=O
2.2 Other Identifiers
2.2.1 UNII
ODU3ZAZ94J
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Bms 742413

2. Bms-742413

3. N-(3-(7-methyl-1h-indazol-5-yl)-1-(4-(1-methylpiperidin-4-yl)-1-oxopropan-2-yl))-4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidine-1-carboxamide

2.3.2 Depositor-Supplied Synonyms

1. Vazegepant

2. Bms-742413

3. Bhv-3500

4. Zavegepant [usan]

5. Odu3zaz94j

6. Bms-742413-01

7. 1337918-83-8

8. Chembl2397415

9. N-[(2r)-3-(7-methyl-1h-indazol-5-yl)-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-1-oxopropan-2-yl]-4-(2-oxo-1h-quinolin-3-yl)piperidine-1-carboxamide

10. 1-piperidinecarboxamide, 4-(1,2-dihydro-2-oxo-3-quinolinyl)-n-((1r)-1-((7-methyl-1h-indazol-5-yl)methyl)-2-(4-(1-methyl-4-piperidinyl)-1-piperazinyl)-2-oxoethyl)-

11. 4-(1,2-dihydro-2-oxo-3-quinolinyl)-n-((1r)-1-((7-methyl-1h-indazol-5-yl)methyl)-2-(4-(1-methyl-4-piperidinyl)-1-piperazinyl)-2-oxoethyl)-1-piperidinecarboxamide

12. Zavegepant [inn]

13. Unii-odu3zaz94j

14. Vazegepant [who-dd]

15. Schembl107428

16. Gtpl11513

17. Ex-a6698

18. Bdbm50436107

19. Bms742413

20. Who 11512

21. Hy-134992

22. Cs-0168642

2.4 Create Date
2011-11-07
3 Chemical and Physical Properties
Molecular Weight 638.8 g/mol
Molecular Formula C36H46N8O3
XLogP33.1
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count6
Rotatable Bond Count6
Exact Mass638.36928736 g/mol
Monoisotopic Mass638.36928736 g/mol
Topological Polar Surface Area117 Ų
Heavy Atom Count47
Formal Charge0
Complexity1160
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

API SUPPLIERS

read-more
read-more

01

Moehs Iberica

Spain

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMoehs Group, a reference company in the production of pharmaceutical active ingredients.

Flag Spain
Digital Content Digital Content
USDMF arrow-down Click Us! arrow-down
CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Moehs Iberica

02

Metrochem API Private Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMetrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Metrochem

03

Axplora

Germany

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAxplora is your partner of choice for complex APIs.

Flag Germany
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Axplora CB

04

Farmhispania

Spain

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothFarmhispania Group, a leading European CDMO in HPAPI Technologies & High Potency Fermentation.

Flag Spain
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Farmhispania

05

HRV Global Life Sciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHRV Global Life Sciences - Market Expansion Leader in Pharmaceuticals.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
HRV Global Life Sciences

06

Jinan Tantu Chemicals

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothJinan Tantu Chemicals offers customized R&D services & production of small molecule APIs & pharmaceutical intermediates.

Flag China
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Jinan Tantu Chemicals

07

TAPI Technology & API Services

Israel

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

Flag Israel
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
TAPI Company Banner

08

Anthem Biosciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

EPS
Not Confirmed
arrow

Anthem Biosciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
EPS
Not Confirmed
USDMF CEP/COS JDMF EU-WCarrow-down NDC KDMF VMF Others AUDIT
blank

09

Zhejiang Tianyu Pharmaceutical Co....

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

EPS
Not Confirmed
arrow

10

Micro Labs Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

EPS
Not Confirmed
arrow
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-moreread-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMoehs Group, a reference company in the production of pharmaceutical active ingredients.

Flag Spain
Digital Content Digital Content

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 41470

Submission : 2025-03-11

Status : Active

Type : II

Moehs Iberica
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EU WC

read-more
read-moreread-more

01

IFT FIRST
Not Confirmed
arrow
arrow
IFT FIRST
Not Confirmed

Zavegepant Hydrochloride IH

Date of Issue : 2022-09-16

Valid Till : 2025-09-15

Written Confirmation Number : WC-0536

Address of the Firm : #49, F1 & F2, Canara Bank Road, Bommasandra Industrial area, Phase 1, Bommasandr...

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

read-more
read-moreread-more

01

IFT FIRST
Not Confirmed
arrow
arrow
IFT FIRST
Not Confirmed

ZAVEGEPANT HYDROCHLORIDE

NDC Package Code : 47848-062

Start Marketing Date : 2023-12-14

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

02

TAPI Croatia Industries Ltd.

Country
IFT FIRST
Not Confirmed
arrow

TAPI Croatia Industries Ltd.

Country
arrow
IFT FIRST
Not Confirmed

ZAVEGEPANT HYDROCHLORIDE

NDC Package Code : 11722-083

Start Marketing Date : 2024-12-16

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

03

TAPI Czech Industries s.r.o.

Country
IFT FIRST
Not Confirmed
arrow

TAPI Czech Industries s.r.o.

Country
arrow
IFT FIRST
Not Confirmed

ZAVEGEPANT HYDROCHLORIDE

NDC Package Code : 84644-062

Start Marketing Date : 2023-12-14

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMoehs Group, a reference company in the production of pharmaceutical active ingredients.

Flag Spain
Digital Content Digital Content

Zavegepant

About the Company : Since its founding in 1962, MOEHS has produced Active Pharmaceutical Ingredients (APIs) for the international pharmaceutical industry. Thanks to a business history of more than 50 ...

Since its founding in 1962, MOEHS has produced Active Pharmaceutical Ingredients (APIs) for the international pharmaceutical industry. Thanks to a business history of more than 50 years, MOEHS has considerable technical experience in the production of these substances. At Moehs Group we have a large tradition and experience in the area of manufacturing of active pharmaceutical and veterinary ingredients, agrochemicals, nutraceutical, cosmetic, as well as fine chemistry in general, with high levels of quality and safety standards-GMP´s, ICH, approved by the FDA and TGA.
Moehs Iberica

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMetrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Flag India
Digital Content Digital Content

Zavegepant

About the Company : Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product gro...

Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product groups and has been approved by ISO 9001-2015, USFDA, WHO GMP, Cofepris & Japanese authorities. Metrochem’s in-depth industry knowledge, & hi-tech & advanced infrastructure, helps it provide quality products to its customers. Note: None of the products will be supplied to the countries where this could conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer
Metrochem

03

Axplora

Germany
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAxplora is your partner of choice for complex APIs.

Flag Germany
Digital Content Digital Content

Zavegepant

About the Company : Axplora, created from the merger of Farmabios, Novasep & PharmaZell, is a leading API manufacturing partner to the world’s leading pharma & biotech companies, delivering top-qual...

Axplora, created from the merger of Farmabios, Novasep & PharmaZell, is a leading API manufacturing partner to the world’s leading pharma & biotech companies, delivering top-quality APIs on time & at scale, to the highest industry standards. It is dedicated to helping pharma companies make critical medicines safely to benefit patients. Leveraging our combined expertise & manufacturing capabilities across 9 industrial sites in the EU & India & an R&D facility in the USA, it offers CDMO services for small molecule APIs & biopharmaceuticals to innovators as well as APIs that address lifestyle-induced respiratory, inflammatory & liver diseases.
Axplora CB

04

Farmhispania

Spain
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothFarmhispania Group, a leading European CDMO in HPAPI Technologies & High Potency Fermentation.

Flag Spain
Digital Content Digital Content

Zavegepant

About the Company : Farmhispania Group comprises two companies in Spain: Farmhispania in Barcelona and Rolabo in Zaragoza. Since its inception, the group has consistently invested in advanced equipmen...

Farmhispania Group comprises two companies in Spain: Farmhispania in Barcelona and Rolabo in Zaragoza. Since its inception, the group has consistently invested in advanced equipment, new technologies, and enhanced capabilities. Significant investments include the implementation of hydrogenation technologies in 2007, HPAPI handling capabilities in 2010, highly potent fermentation capabilities in 2014, and the expansion of large-scale preparative chromatography in 2015. Additionally, Farmhispania Group actively collaborates on numerous projects with various universities and research organizations both nationally and internationally.
Farmhispania

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHRV Global Life Sciences - Market Expansion Leader in Pharmaceuticals.

Flag India
Digital Content Digital Content

Zavegepant Hydrochloride

About the Company : HRV Global is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It...

HRV Global is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It offers services such as sourcing, manufacturing & supply, helping partners enter new markets worldwide. Its strong partnerships with major players in the pharma and food additive industries help HRV Global effectively promote projects and products. HRV Global represents over 30 large Indian drugmakers, primarily targeting Europe, the US & the Middle East markets. Headquartered in India, HRV Global has offices in the US, Switzerland, Dubai, Lithuania & Turkey.
HRV Global Life Sciences

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothJinan Tantu Chemicals offers customized R&D services & production of small molecule APIs & pharmaceutical intermediates.

Flag China
Digital Content Digital Content

Zavegepant

About the Company : Jinan Tantu Chemicals Co., Ltd. operates as a Contract Development and Manufacturing Organization (CDMO) that serves pharmaceutical companies worldwide. Our core services include c...

Jinan Tantu Chemicals Co., Ltd. operates as a Contract Development and Manufacturing Organization (CDMO) that serves pharmaceutical companies worldwide. Our core services include customized R&D as well as the production of small molecule pharmaceutical intermediates and Active Pharmaceutical Ingredients (APIs) for both international and domestic pharmaceutical firms. Our capabilities span from laboratory-scale kilograms to commercial ton-scale production. Additionally, we are committed to independent research and development, as well as the production and sales of high-end pharmaceutical intermediates and API products.
Jinan Tantu Chemicals

07

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

Flag Israel
Digital Content Digital Content

Zavegepant HCl

About the Company : Founded in 1935, TAPI Technology & API Services has a long-standing tradition of advancing health through innovation and dedication. Today, we proudly build upon this legacy, drivi...

Founded in 1935, TAPI Technology & API Services has a long-standing tradition of advancing health through innovation and dedication. Today, we proudly build upon this legacy, driving progress in the pharmaceutical industry. Leveraging our extensive experience and world-class expertise, we deliver one of the most comprehensive API portfolios in the industry with over 350 Products portfolio. Additionally, we provide tailored CDMO services, harnessing our proficiency in diverse technologies to meet our partners' unique needs, ensuring flexibility and excellence in every project.
TAPI Company Banner

08

Apicore

India
IFT FIRST
Not Confirmed
arrow

Apicore

India
arrow
IFT FIRST
Not Confirmed

Zavegepant HCl

About the Company : Apicore LLC, a wholly owned subsidiary of RK Pharma Inc is a leading process R&D and API manufacturing service provider for the worldwide pharmaceutical industry. We offer a wide p...

Apicore LLC, a wholly owned subsidiary of RK Pharma Inc is a leading process R&D and API manufacturing service provider for the worldwide pharmaceutical industry. We offer a wide portfolio of services ranging from API’s for the generic industry to custom synthesis for early phase pharmaceutical research and branded products. Our USFDA approved facilities in India (Visakhapatnam, Andhra Pradesh and Vadodara, Gujarat) are both equipped with state-of-the-art analytical and research capabilities. While our worldwide network of locations seamlessly integrate with each other, each unit also independently houses a full
blank

09

IFT FIRST
Not Confirmed
arrow
arrow
IFT FIRST
Not Confirmed

Zavegepant HCl

About the Company : Micro Labs Limited is a diversified healthcare company with cutting-edge R&D, advanced manufacturing facilities, and a strong distribution network. It ranks among India's top pharm...

Micro Labs Limited is a diversified healthcare company with cutting-edge R&D, advanced manufacturing facilities, and a strong distribution network. It ranks among India's top pharmaceutical companies, with a leading presence in cardiology, diabetology, anti-infectives, ophthalmology, and pain management. The company is known for its high-quality medicines, including the popular fever management brand, Dolo. Micro Labs continues to grow through innovation, research, and global expansion, delivering healthcare solutions that meet international standards.
blank

10

IFT FIRST
Not Confirmed
arrow
arrow
IFT FIRST
Not Confirmed

Zavegepant

About the Company : Saptagir Laboratories Private incorporated in 2016, is a manufacturer and supplier of Active Pharmaceutical Ingredients (APIs) and Intermediates for a wide range of therapeutic cat...

Saptagir Laboratories Private incorporated in 2016, is a manufacturer and supplier of Active Pharmaceutical Ingredients (APIs) and Intermediates for a wide range of therapeutic categories specifically focusing on Anti-Fungal and Anti-Platelets. Our vision is to attain market leadership in development of innovator molecules for the domestic and export market.
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1711564200,"product":"FINE ORGANIC COMPOUND 100%EOU BATCH# A012320172 ZAVEGEPANT HYDROCHLORIDE\/ API (POST TRAY DRIED 16 HOURS) POST INITIAL SI","address":"PLOT.NO.49,CANARA BANK ROAD,BOMMASANDRA INDL.AREA,","city":"PHASE-I,BANGALORE","supplier":"ANTHEM BIOSCIENCES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"LONDON METROPOLITAN","customer":"PROJECT MANAGER","customerCountry":"UNITED KINGDOM","quantity":"0.05","actualQuantity":"50","unit":"GMS","unitRateFc":"0.2","totalValueFC":"9.5","currency":"USD","unitRateINR":15.7302,"date":"28-Mar-2024","totalValueINR":"786.51","totalValueInUsd":"9.5","indian_port":"Bangalore Air","hs_no":"29333990","bill_no":"8716201","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Bangalore Air","supplierAddress":"PLOT.NO.49,CANARA BANK ROAD,BOMMASANDRA INDL.AREA,, PHASE-I,BANGALORE","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1711564200,"product":"FINE ORGANIC COMPOUND 100%EOU BATCH# A012320172 ZAVEGEPANT HYDROCHLORIDE\/ API OFF-LOADED INTO LLDPE BAGS POST ACETONE SL","address":"PLOT.NO.49,CANARA BANK ROAD,BOMMASANDRA INDL.AREA,","city":"PHASE-I,BANGALORE","supplier":"ANTHEM BIOSCIENCES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"LONDON METROPOLITAN","customer":"PROJECT MANAGER","customerCountry":"UNITED KINGDOM","quantity":"0.03","actualQuantity":"31.6","unit":"GMS","unitRateFc":"0.3","totalValueFC":"7.1","currency":"USD","unitRateINR":18.667088607594934,"date":"28-Mar-2024","totalValueINR":"589.88","totalValueInUsd":"7.1","indian_port":"Bangalore Air","hs_no":"29333990","bill_no":"8716201","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Bangalore Air","supplierAddress":"PLOT.NO.49,CANARA BANK ROAD,BOMMASANDRA INDL.AREA,, PHASE-I,BANGALORE","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1711564200,"product":"FINE ORGANIC COMPOUND 100%EOU BATCH# A012320172 ZAVEGEPANT HYDROCHLORIDE\/ API OFF-LOADED INTO LLDPE TRANSPARENT POLYTHEN","address":"PLOT.NO.49,CANARA BANK ROAD,BOMMASANDRA INDL.AREA,","city":"PHASE-I,BANGALORE","supplier":"ANTHEM BIOSCIENCES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"LONDON METROPOLITAN","customer":"PROJECT MANAGER","customerCountry":"UNITED KINGDOM","quantity":"0.04","actualQuantity":"35","unit":"GMS","unitRateFc":"0.3","totalValueFC":"7.1","currency":"USD","unitRateINR":16.853714285714286,"date":"28-Mar-2024","totalValueINR":"589.88","totalValueInUsd":"7.1","indian_port":"Bangalore Air","hs_no":"29333990","bill_no":"8716201","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Bangalore Air","supplierAddress":"PLOT.NO.49,CANARA BANK ROAD,BOMMASANDRA INDL.AREA,, PHASE-I,BANGALORE","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1711564200,"product":"FINE ORGANIC COMPOUND 100%EOU BATCH# A012320172 ZAVEGEPANT HYDROCHLORIDE\/ API POST METAL DETECTION (STEP-157A)","address":"PLOT.NO.49,CANARA BANK ROAD,BOMMASANDRA INDL.AREA,","city":"PHASE-I,BANGALORE","supplier":"ANTHEM BIOSCIENCES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"LONDON METROPOLITAN","customer":"PROJECT MANAGER","customerCountry":"UNITED KINGDOM","quantity":"0.05","actualQuantity":"50","unit":"GMS","unitRateFc":"0.2","totalValueFC":"9.5","currency":"USD","unitRateINR":15.7302,"date":"28-Mar-2024","totalValueINR":"786.51","totalValueInUsd":"9.5","indian_port":"Bangalore Air","hs_no":"29333990","bill_no":"8716201","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Bangalore Air","supplierAddress":"PLOT.NO.49,CANARA BANK ROAD,BOMMASANDRA INDL.AREA,, PHASE-I,BANGALORE","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1711564200,"product":"FINE ORGANIC COMPOUND 100%EOU BATCH# A012320172 ZAVEGEPANT HYDROCHLORIDE\/ DRIEDAPI OFF LOADED INTO LLDPE TRANSPARENT PO","address":"PLOT.NO.49,CANARA BANK ROAD,BOMMASANDRA INDL.AREA,","city":"PHASE-I,BANGALORE","supplier":"ANTHEM BIOSCIENCES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"LONDON METROPOLITAN","customer":"PROJECT MANAGER","customerCountry":"UNITED KINGDOM","quantity":"0.05","actualQuantity":"50","unit":"GMS","unitRateFc":"0.2","totalValueFC":"9.5","currency":"USD","unitRateINR":15.7302,"date":"28-Mar-2024","totalValueINR":"786.51","totalValueInUsd":"9.5","indian_port":"Bangalore Air","hs_no":"29333990","bill_no":"8716201","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Bangalore Air","supplierAddress":"PLOT.NO.49,CANARA BANK ROAD,BOMMASANDRA INDL.AREA,, PHASE-I,BANGALORE","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1711564200,"product":"FINE ORGANIC COMPOUND 100%EOU BATCH# A012320172 ZAVEGEPANT HYDROCHLORIDE\/ DRIEDAPI POST SIEVED AND OFF LOADED INTO LLDP","address":"PLOT.NO.49,CANARA BANK ROAD,BOMMASANDRA INDL.AREA,","city":"PHASE-I,BANGALORE","supplier":"ANTHEM BIOSCIENCES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"LONDON METROPOLITAN","customer":"PROJECT MANAGER","customerCountry":"UNITED KINGDOM","quantity":"0.05","actualQuantity":"50","unit":"GMS","unitRateFc":"0.2","totalValueFC":"9.5","currency":"USD","unitRateINR":15.7302,"date":"28-Mar-2024","totalValueINR":"786.51","totalValueInUsd":"9.5","indian_port":"Bangalore Air","hs_no":"29333990","bill_no":"8716201","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Bangalore Air","supplierAddress":"PLOT.NO.49,CANARA BANK ROAD,BOMMASANDRA INDL.AREA,, PHASE-I,BANGALORE","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1711564200,"product":"FINE ORGANIC COMPOUND 100%EOU BATCH# A012440001 ZAVEGEPANT HYDROCHLORIDE\/ API PRE-METAL DETECTION (STEP#365A)","address":"PLOT.NO.49,CANARA BANK ROAD,BOMMASANDRA INDL.AREA,","city":"PHASE-I,BANGALORE","supplier":"ANTHEM BIOSCIENCES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"LONDON METROPOLITAN","customer":"PROJECT MANAGER","customerCountry":"UNITED KINGDOM","quantity":"0.05","actualQuantity":"50","unit":"GMS","unitRateFc":"0.2","totalValueFC":"9.5","currency":"USD","unitRateINR":15.7302,"date":"28-Mar-2024","totalValueINR":"786.51","totalValueInUsd":"9.5","indian_port":"Bangalore Air","hs_no":"29333990","bill_no":"8716201","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Bangalore Air","supplierAddress":"PLOT.NO.49,CANARA BANK ROAD,BOMMASANDRA INDL.AREA,, PHASE-I,BANGALORE","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1711564200,"product":"FINE ORGANIC COMPOUND 100%EOU BATCH# A012440001 ZAVEGEPANT HYDROCHLORIDE\/ DRIEDAPI FROM TRAY DRYING (WITH LINERS)(STEP#","address":"PLOT.NO.49,CANARA BANK ROAD,BOMMASANDRA INDL.AREA,","city":"PHASE-I,BANGALORE","supplier":"ANTHEM BIOSCIENCES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"LONDON METROPOLITAN","customer":"PROJECT MANAGER","customerCountry":"UNITED KINGDOM","quantity":"0.05","actualQuantity":"50","unit":"GMS","unitRateFc":"0.2","totalValueFC":"9.5","currency":"USD","unitRateINR":15.7302,"date":"28-Mar-2024","totalValueINR":"786.51","totalValueInUsd":"9.5","indian_port":"Bangalore Air","hs_no":"29333990","bill_no":"8716201","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Bangalore Air","supplierAddress":"PLOT.NO.49,CANARA BANK ROAD,BOMMASANDRA INDL.AREA,, PHASE-I,BANGALORE","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1711564200,"product":"FINE ORGANIC COMPOUND 100%EOU BATCH# A012440001 ZAVEGEPANT HYDROCHLORIDE\/ DRIEDAPI OFF LOADED INTO LLDPE BAGS (STEP#346","address":"PLOT.NO.49,CANARA BANK ROAD,BOMMASANDRA INDL.AREA,","city":"PHASE-I,BANGALORE","supplier":"ANTHEM BIOSCIENCES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"LONDON METROPOLITAN","customer":"PROJECT MANAGER","customerCountry":"UNITED KINGDOM","quantity":"0.05","actualQuantity":"50","unit":"GMS","unitRateFc":"0.2","totalValueFC":"9.5","currency":"USD","unitRateINR":15.7302,"date":"28-Mar-2024","totalValueINR":"786.51","totalValueInUsd":"9.5","indian_port":"Bangalore Air","hs_no":"29333990","bill_no":"8716201","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Bangalore Air","supplierAddress":"PLOT.NO.49,CANARA BANK ROAD,BOMMASANDRA INDL.AREA,, PHASE-I,BANGALORE","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1711564200,"product":"FINE ORGANIC COMPOUND 100%EOU BATCH# A012440001 ZAVEGEPANT HYDROCHLORIDE\/ DRIEDAPI POST SIEVED AND OFF LOADED INTO LLDP","address":"PLOT.NO.49,CANARA BANK ROAD,BOMMASANDRA INDL.AREA,","city":"PHASE-I,BANGALORE","supplier":"ANTHEM BIOSCIENCES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"LONDON METROPOLITAN","customer":"PROJECT MANAGER","customerCountry":"UNITED KINGDOM","quantity":"0.05","actualQuantity":"50","unit":"GMS","unitRateFc":"0.2","totalValueFC":"9.5","currency":"USD","unitRateINR":15.7302,"date":"28-Mar-2024","totalValueINR":"786.51","totalValueInUsd":"9.5","indian_port":"Bangalore Air","hs_no":"29333990","bill_no":"8716201","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Bangalore Air","supplierAddress":"PLOT.NO.49,CANARA BANK ROAD,BOMMASANDRA INDL.AREA,, PHASE-I,BANGALORE","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1711564200,"product":"FINE ORGANIC COMPOUND 100%EOU BATCH# A012440001 ZAVEGEPANT HYDROCHLORIDE\/ DRIEDAPI PRE SIEVED (STEP#361)","address":"PLOT.NO.49,CANARA BANK ROAD,BOMMASANDRA INDL.AREA,","city":"PHASE-I,BANGALORE","supplier":"ANTHEM BIOSCIENCES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"LONDON METROPOLITAN","customer":"PROJECT MANAGER","customerCountry":"UNITED KINGDOM","quantity":"0.05","actualQuantity":"50","unit":"GMS","unitRateFc":"0.2","totalValueFC":"9.5","currency":"USD","unitRateINR":15.7302,"date":"28-Mar-2024","totalValueINR":"786.51","totalValueInUsd":"9.5","indian_port":"Bangalore Air","hs_no":"29333990","bill_no":"8716201","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Bangalore Air","supplierAddress":"PLOT.NO.49,CANARA BANK ROAD,BOMMASANDRA INDL.AREA,, PHASE-I,BANGALORE","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1711564200,"product":"FINE ORGANIC COMPOUND 100%EOU BATCH#A012440001 ZAVEGEPANT HYDROCHLORIDE\/ API (POST TRAY DRIED 16HRS) PRE INITIAL SIEVING","address":"PLOT.NO.49,CANARA BANK ROAD,BOMMASANDRA INDL.AREA,","city":"PHASE-I,BANGALORE","supplier":"ANTHEM BIOSCIENCES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"LONDON METROPOLITAN","customer":"PROJECT MANAGER","customerCountry":"UNITED KINGDOM","quantity":"0.05","actualQuantity":"50","unit":"GMS","unitRateFc":"0.2","totalValueFC":"9.5","currency":"USD","unitRateINR":15.7302,"date":"28-Mar-2024","totalValueINR":"786.51","totalValueInUsd":"9.5","indian_port":"Bangalore Air","hs_no":"29333990","bill_no":"8716201","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Bangalore Air","supplierAddress":"PLOT.NO.49,CANARA BANK ROAD,BOMMASANDRA INDL.AREA,, PHASE-I,BANGALORE","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1711564200,"product":"FINE ORGANIC COMPOUND 100%EOU BATCH#A012440001 ZAVEGEPANT HYDROCHLORIDE\/ API POST N-HEPTANE SLURRY-3 (STEP#138C)","address":"PLOT.NO.49,CANARA BANK ROAD,BOMMASANDRA INDL.AREA,","city":"PHASE-I,BANGALORE","supplier":"ANTHEM BIOSCIENCES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"LONDON METROPOLITAN","customer":"PROJECT MANAGER","customerCountry":"UNITED KINGDOM","quantity":"0.04","actualQuantity":"42","unit":"GMS","unitRateFc":"0.2","totalValueFC":"7.1","currency":"USD","unitRateINR":14.044761904761904,"date":"28-Mar-2024","totalValueINR":"589.88","totalValueInUsd":"7.1","indian_port":"Bangalore Air","hs_no":"29333990","bill_no":"8716201","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Bangalore Air","supplierAddress":"PLOT.NO.49,CANARA BANK ROAD,BOMMASANDRA INDL.AREA,, PHASE-I,BANGALORE","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1711564200,"product":"FINE ORGANIC COMPOUND 100%EOU BATCH#A012440001 ZAVEGEPANT HYDROCHLORIDE\/ DRIED API FROM TRAY DRYING (WITH LINERS) STEP","address":"PLOT.NO.49,CANARA BANK ROAD,BOMMASANDRA INDL.AREA,","city":"PHASE-I,BANGALORE","supplier":"ANTHEM BIOSCIENCES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"LONDON METROPOLITAN","customer":"PROJECT MANAGER","customerCountry":"UNITED KINGDOM","quantity":"0.05","actualQuantity":"50","unit":"GMS","unitRateFc":"0.2","totalValueFC":"9.5","currency":"USD","unitRateINR":15.7302,"date":"28-Mar-2024","totalValueINR":"786.51","totalValueInUsd":"9.5","indian_port":"Bangalore Air","hs_no":"29333990","bill_no":"8716201","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Bangalore Air","supplierAddress":"PLOT.NO.49,CANARA BANK ROAD,BOMMASANDRA INDL.AREA,, PHASE-I,BANGALORE","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1742495400,"product":"FINE ORGANIC COMPOUND-WE INTEND TO CLAIMUNDERRODTEPSCHEME (B\/N:A012440307)ZAVEGEPANT HYDROCHLORID","address":"PLOT.NO.49,CANARA BANK ROAD,","city":"PHASE-I,BANGALORE","supplier":"ANTHEM BIOSCIENCES LTD","supplierCountry":"INDIA","foreign_port":"PANAMA CITY -","customer":"PROJECT MANAGER","customerCountry":"PANAMA","quantity":"121.50","actualQuantity":"121.5","unit":"KGS","unitRateFc":"12509.8","totalValueFC":"1502080.8","currency":"USD","unitRateINR":1070836.3152263374,"date":"21-Mar-2025","totalValueINR":"130106612.3","totalValueInUsd":"1502080.8","indian_port":"Bangalore Air","hs_no":"29333990","bill_no":"9228612","productDescription":"API","marketType":"","country":"PANAMA","selfForZScoreResived":"Pharma Grade","supplierPort":"Bangalore Air","supplierAddress":"PLOT.NO.49,CANARA BANK ROAD,, PHASE-I,BANGALORE","customerAddress":""}]
28-Mar-2024
21-Mar-2025
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API/FDF Prices: Book a Demo to explore the features and consider upgrading later

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Drugs in Development

read-more
read-more

Details:

Zavzpret (zavegepant) is a calcitonin gene-related peptide receptor antagonist. CGRP antagonists have been shown pain relief during migraine induced headaches.


Lead Product(s): Zavegepant HCl

Therapeutic Area: Neurology Brand Name: Zavzpret

Study Phase: Approved FDFProduct Type: Other Small Molecule

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable October 03, 2023

blank

01

Pfizer Inc

U.S.A
arrow
IFT FIRST
Not Confirmed

Pfizer Inc

U.S.A
arrow
IFT FIRST
Not Confirmed

Details : Zavzpret (zavegepant) is a calcitonin gene-related peptide receptor antagonist. CGRP antagonists have been shown pain relief during migraine induced headaches.

Product Name : Zavzpret

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

October 03, 2023

blank

Details:

Pfizer has given Royalty Pharma an accelerated milestone payment following the US approval of its migraine nasal spray, Zavzpret (zavegepant). Zavzpret was approved by the U.S. FDA, which provides another important new treatment option for migraine patients.


Lead Product(s): Zavegepant HCl

Therapeutic Area: Neurology Brand Name: Zavzpret

Study Phase: Approved FDFProduct Type: Other Small Molecule

Sponsor: Pfizer Inc

Deal Size: $475.0 million Upfront Cash: Undisclosed

Deal Type: Agreement March 15, 2023

blank

02

IFT FIRST
Not Confirmed
IFT FIRST
Not Confirmed

Details : Pfizer has given Royalty Pharma an accelerated milestone payment following the US approval of its migraine nasal spray, Zavzpret (zavegepant). Zavzpret was approved by the U.S. FDA, which provides another important new treatment option for migraine patie...

Product Name : Zavzpret

Product Type : Other Small Molecule

Upfront Cash : Undisclosed

March 15, 2023

blank

Details:

Complete data from the Phase 3 BHV3500 (zavegepant) nasal spray study highlight its ultra-rapid pain relief in as little as 15 minutes that lasts through 48 hours after a single dose.


Lead Product(s): Zavegepant HCl

Therapeutic Area: Neurology Brand Name: BHV-3500

Study Phase: Phase IIIProduct Type: Other Small Molecule

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable June 13, 2022

blank

03

IFT FIRST
Not Confirmed
IFT FIRST
Not Confirmed

Details : Complete data from the Phase 3 BHV3500 (zavegepant) nasal spray study highlight its ultra-rapid pain relief in as little as 15 minutes that lasts through 48 hours after a single dose.

Product Name : BHV-3500

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

June 13, 2022

blank

Details:

In the pivotal studies, BHV3500 (zavegepant) was statistically superior to placebo on the coprimary regulatory endpoints of superiority to placebo at 2 hours for pain freedom and freedom from the migraine-associated most bothersome.


Lead Product(s): Zavegepant HCl

Therapeutic Area: Neurology Brand Name: BHV-3500

Study Phase: Phase IIIProduct Type: Other Small Molecule

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable May 23, 2022

blank

04

IFT FIRST
Not Confirmed
IFT FIRST
Not Confirmed

Details : In the pivotal studies, BHV3500 (zavegepant) was statistically superior to placebo on the coprimary regulatory endpoints of superiority to placebo at 2 hours for pain freedom and freedom from the migraine-associated most bothersome.

Product Name : BHV-3500

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

May 23, 2022

blank

Details:

Biohaven plans to file a NDA for BHV-3500 (zavegepant) with the USFDA in 1Q2022,showed ultra-rapid pain relief at the earliest measured time point of 15 minutes and sustained efficacy through 48 hours after a single intranasal dose.


Lead Product(s): Zavegepant HCl

Therapeutic Area: Neurology Brand Name: BHV-3500

Study Phase: Phase II/ Phase IIIProduct Type: Other Small Molecule

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable June 12, 2021

blank

05

IFT FIRST
Not Confirmed
IFT FIRST
Not Confirmed

Details : Biohaven plans to file a NDA for BHV-3500 (zavegepant) with the USFDA in 1Q2022,showed ultra-rapid pain relief at the earliest measured time point of 15 minutes and sustained efficacy through 48 hours after a single intranasal dose.

Product Name : BHV-3500

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

June 12, 2021

blank

Details:

Zavegepant is a high affinity, selective and structurally unique, third generation, CGRP receptor antagonist in development for both migraine and non-migraine CGRP-mediated diseases.


Lead Product(s): Zavegepant HCl

Therapeutic Area: Neurology Brand Name: BHV-3500

Study Phase: Phase II/ Phase IIIProduct Type: Other Small Molecule

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable March 29, 2021

blank

06

IFT FIRST
Not Confirmed
IFT FIRST
Not Confirmed

Details : Zavegepant is a high affinity, selective and structurally unique, third generation, CGRP receptor antagonist in development for both migraine and non-migraine CGRP-mediated diseases.

Product Name : BHV-3500

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

March 29, 2021

blank

Details:

Zavegepant is a third generation, high affinity, selective and structurally unique, small molecule CGRP receptor antagonist in development for both migraine and non-migraine indications including COVID-19 associated lung inflammation.


Lead Product(s): Zavegepant HCl

Therapeutic Area: Neurology Brand Name: BHV-3500

Study Phase: Phase II/ Phase IIIProduct Type: Other Small Molecule

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable October 09, 2020

blank

07

IFT FIRST
Not Confirmed
IFT FIRST
Not Confirmed

Details : Zavegepant is a third generation, high affinity, selective and structurally unique, small molecule CGRP receptor antagonist in development for both migraine and non-migraine indications including COVID-19 associated lung inflammation.

Product Name : BHV-3500

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

October 09, 2020

blank

Details:

Biohaven plans to study intranasal vazegepant, a high affinity, selective and structurally unique, small molecule CGRP receptor antagonist, in pulmonary complications of COVID-19 disease.


Lead Product(s): Zavegepant HCl

Therapeutic Area: Infections and Infectious Diseases Brand Name: BHV-3500

Study Phase: Phase II/ Phase IIIProduct Type: Other Small Molecule

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable September 04, 2020

blank

08

IFT FIRST
Not Confirmed
IFT FIRST
Not Confirmed

Details : Biohaven plans to study intranasal vazegepant, a high affinity, selective and structurally unique, small molecule CGRP receptor antagonist, in pulmonary complications of COVID-19 disease.

Product Name : BHV-3500

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

September 04, 2020

blank

Details:

Funding will advance the Biohaven's CGRP receptor antagonist program through the development of zavegepant (vazegepant). The zavegepant program encompasses intranasal zavegepant as well as oral zavegepant for migraine prevention and non-migraine indications.


Lead Product(s): Zavegepant HCl

Therapeutic Area: Neurology Brand Name: BHV-3500

Study Phase: Phase II/ Phase IIIProduct Type: Other Small Molecule

Sponsor: Royalty Pharma

Deal Size: $450.0 million Upfront Cash: Undisclosed

Deal Type: Funding July 08, 2020

blank

09

IFT FIRST
Not Confirmed
IFT FIRST
Not Confirmed

Details : Funding will advance the Biohaven's CGRP receptor antagonist program through the development of zavegepant (vazegepant). The zavegepant program encompasses intranasal zavegepant as well as oral zavegepant for migraine prevention and non-migraine indicati...

Product Name : BHV-3500

Product Type : Other Small Molecule

Upfront Cash : Undisclosed

July 08, 2020

blank

Details:

The Company addressed all issues raised by the FDA and will advance the 10 mg dose of intranasal vazegepant into a double-blind, placebo-controlled Phase 3 clinical trial.


Lead Product(s): Zavegepant HCl

Therapeutic Area: Neurology Brand Name: BHV-3500

Study Phase: Phase II/ Phase IIIProduct Type: Other Small Molecule

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable March 23, 2020

blank

10

IFT FIRST
Not Confirmed
IFT FIRST
Not Confirmed

Details : The Company addressed all issues raised by the FDA and will advance the 10 mg dose of intranasal vazegepant into a double-blind, placebo-controlled Phase 3 clinical trial.

Product Name : BHV-3500

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

March 23, 2020

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

INTERMEDIATE SUPPLIERS

read-more
read-more

01

Vamsi Labs

India
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothVamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

CAS Number : 1445-73-4

End Use API : Zavegepant HCl

About The Company : Vamsi Labs, established in 1991, is a leading Indian API manufacturer. Specializing in anti-asthmatic, anti-migraine & anti-psychotic APIs, it caters to domesti...

Vamsi Labs

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTagoor's product development expertise, backed by our comprehensive understanding of the processes, helps us offer high-quality APIs.

CAS Number : 1445-73-4

End Use API : Zavegepant HCl

About The Company : Tagoor Laboratories, established in 2018, is a part of the Tagoor Group. It specializes in providing APIs, advanced intermediates and key starting materials for...

Tagoor Laboratories

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPorton Pharma Solutions: Value creation via innovation & discovery through technical platforms.

CAS Number : 1414976-14-9

End Use API : Zavegepant HCl

About The Company : Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchange in 2014. Our R&D, manufacturing & ope...

Porton Company Banner

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPorton Pharma Solutions: Value creation via innovation & discovery through technical platforms.

CAS Number : 349535-15-5

End Use API : Zavegepant HCl

About The Company : Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchange in 2014. Our R&D, manufacturing & ope...

Porton Company Banner

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPorton Pharma Solutions: Value creation via innovation & discovery through technical platforms.

CAS Number : 855778-84-6

End Use API : Zavegepant HCl

About The Company : Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchange in 2014. Our R&D, manufacturing & ope...

Porton Company Banner

06

IFT FIRST
Not Confirmed
arrow
IFT FIRST
Not Confirmed
arrow

CAS Number : 23995-88-2

End Use API : Zavegepant HCl

About The Company : Founded with a mission to transform strategic capital into specialty chemicals, Ami Group focuses on Agrochemicals, Cosmetics, and Polymers. Ami Organics Ltd. i...

blank

07

IFT FIRST
Not Confirmed
arrow
IFT FIRST
Not Confirmed
arrow

CAS Number : 1414976-14-9

End Use API : Zavegepant HCl

About The Company : Founded with a mission to transform strategic capital into specialty chemicals, Ami Group focuses on Agrochemicals, Cosmetics, and Polymers. Ami Organics Ltd. i...

blank

08

IFT FIRST
Not Confirmed
arrow
IFT FIRST
Not Confirmed
arrow

CAS Number : 855778-84-6

End Use API : Zavegepant HCl

About The Company : Founded with a mission to transform strategic capital into specialty chemicals, Ami Group focuses on Agrochemicals, Cosmetics, and Polymers. Ami Organics Ltd. i...

blank

09

AstaTech

U.S.A
IFT FIRST
Not Confirmed
arrow

AstaTech

U.S.A
IFT FIRST
Not Confirmed
arrow

CAS Number : 1414976-14-9

End Use API : Zavegepant HCl

About The Company : Located in Bristol, Pennsylvania, AstaTech is one of the oldest established U.S. Contract Research Organizations (CRO). We are dedicated to providing high quali...

blank

10

Biosynth AG

Switzerland
IFT FIRST
Not Confirmed
arrow

Biosynth AG

Switzerland
IFT FIRST
Not Confirmed
arrow

CAS Number : 1414976-14-9

End Use API : Zavegepant HCl

About The Company : Biosynth is an innovative life sciences reagents, custom synthesis and manufacturing services company. We are by scientists, for scientists, securing supply c...

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

read-more
read-more

01

Pfizer Inc

U.S.A
IFT FIRST
Not Confirmed
arrow

Pfizer Inc

U.S.A
arrow
IFT FIRST
Not Confirmed

ZAVEGEPANT HYDROCHLORIDE

Brand Name : ZAVZPRET

Dosage Form : SPRAY, METERED;NASAL

Dosage Strength : EQ 10MG BASE/SPRAY

Packaging :

Approval Date : 2023-03-09

Application Number : 216386

Regulatory Info : RX

Registration Country : USA

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

read-more
read-more

01

PFIZER

U.S.A
IFT FIRST
Not Confirmed
arrow

PFIZER

U.S.A
arrow
IFT FIRST
Not Confirmed

ZAVEGEPANT HYDROCHLORIDE

Brand Name : ZAVZPRET

Dosage Form : SPRAY, METERED;NASAL

Dosage Strength : EQ 10MG BASE/SPRAY

Approval Date : 2023-03-09

Application Number : 216386

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

US Medicaid Prescriptions

read-more
read-more

01

arrow
IFT FIRST
Not Confirmed
arrow
IFT FIRST
Not Confirmed

Company : Pfizer US Pharm

Zavegepant HCl

Drug Cost (USD) : 2,306,719

Year : 2023

Prescribers : 999

Prescriptions : 1847

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

US Patents

read-more
read-more

01

arrow
IFT FIRST
Not Confirmed

PFIZER

U.S.A
arrow
IFT FIRST
Not Confirmed

ZAVEGEPANT HYDROCHLORIDE

US Patent Number : 8481546

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 216386

Patent Use Code : U-3555

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-10-07

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Looking for 1337918-83-8 / Zavegepant HCl API manufacturers, exporters & distributors?

Zavegepant HCl manufacturers, exporters & distributors 1

99

PharmaCompass offers a list of Zavegepant HCl API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Zavegepant HCl manufacturer or Zavegepant HCl supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Zavegepant HCl manufacturer or Zavegepant HCl supplier.

PharmaCompass also assists you with knowing the Zavegepant HCl API Price utilized in the formulation of products. Zavegepant HCl API Price is not always fixed or binding as the Zavegepant HCl Price is obtained through a variety of data sources. The Zavegepant HCl Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Zavegepant HCl

Synonyms

Vazegepant, Bms-742413, Bhv-3500, Zavegepant [usan], Odu3zaz94j, Bms-742413-01

Cas Number

1337918-83-8

Unique Ingredient Identifier (UNII)

ODU3ZAZ94J

About Zavegepant HCl

Zavegepant is a highly soluble small molecule calcitonin gene related peptide (CGRP) receptor antagonist, with potential analgesic and immunomodulating activities. Upon administration, zavegepant targets, binds to and inhibits the activity of CGRP receptors located on mast cells in the brain. This may inhibit neurogenic inflammation caused by trigeminal nerve release of CGRP. In addition, by blocking the CGRP receptors located in smooth muscle cells within vessel walls, zavegepant inhibits the pathologic dilation of intracranial arteries. Zavegepant, by blocking the CGRP receptors, also suppresses the transmission of pain by inhibiting the central relay of pain signals from the trigeminal nerve to the caudal trigeminal nucleus. Altogether, this may relieve migraine. As CGRP receptors induce the release of pro-inflammatory mediators, such as interleukin-6 (IL-6), from inflammatory cells, zavegepant may prevent an IL-6-mediated inflammatory response. Zavegepant may also inhibit the CGRP-mediated induction of eosinophil migration and the stimulation of beta-integrin-mediated T cell adhesion to fibronectin at the site of inflammation, and may abrogate the CGRP-mediated polarization of the T cell response towards the pro-inflammatory state characterized by Th17 and IL-17. This may improve lung inflammation and oxygenation, prevent edema, and further lung injury. CGRP, a 37 amino-acid peptide expressed in and released from a subset of polymodal primary sensory neurons of the trigeminal ganglion and nerve fibers projecting to the airways and by pulmonary neuroendocrine cells, plays an important role in pain transmission, inflammation, and neurogenic vasodilatation. It is released upon acute lung injury and upregulation of transient receptor potential (TRP) channels.

Zavegepant Manufacturers

A Zavegepant manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Zavegepant, including repackagers and relabelers. The FDA regulates Zavegepant manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Zavegepant API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Zavegepant manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Zavegepant Suppliers

A Zavegepant supplier is an individual or a company that provides Zavegepant active pharmaceutical ingredient (API) or Zavegepant finished formulations upon request. The Zavegepant suppliers may include Zavegepant API manufacturers, exporters, distributors and traders.

click here to find a list of Zavegepant suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Zavegepant USDMF

A Zavegepant DMF (Drug Master File) is a document detailing the whole manufacturing process of Zavegepant active pharmaceutical ingredient (API) in detail. Different forms of Zavegepant DMFs exist exist since differing nations have different regulations, such as Zavegepant USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Zavegepant DMF submitted to regulatory agencies in the US is known as a USDMF. Zavegepant USDMF includes data on Zavegepant's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Zavegepant USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Zavegepant suppliers with USDMF on PharmaCompass.

Zavegepant WC

A Zavegepant written confirmation (Zavegepant WC) is an official document issued by a regulatory agency to a Zavegepant manufacturer, verifying that the manufacturing facility of a Zavegepant active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Zavegepant APIs or Zavegepant finished pharmaceutical products to another nation, regulatory agencies frequently require a Zavegepant WC (written confirmation) as part of the regulatory process.

click here to find a list of Zavegepant suppliers with Written Confirmation (WC) on PharmaCompass.

Zavegepant NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Zavegepant as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Zavegepant API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Zavegepant as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Zavegepant and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Zavegepant NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Zavegepant suppliers with NDC on PharmaCompass.

Zavegepant GMP

Zavegepant Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Zavegepant GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Zavegepant GMP manufacturer or Zavegepant GMP API supplier for your needs.

Zavegepant CoA

A Zavegepant CoA (Certificate of Analysis) is a formal document that attests to Zavegepant's compliance with Zavegepant specifications and serves as a tool for batch-level quality control.

Zavegepant CoA mostly includes findings from lab analyses of a specific batch. For each Zavegepant CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Zavegepant may be tested according to a variety of international standards, such as European Pharmacopoeia (Zavegepant EP), Zavegepant JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Zavegepant USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty